![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | A61K 31/275 | (2006.01) |
C07C 255/25 | (2006.01) | ||
C07C 255/46 | (2006.01) | ||
C07C 311/37 | (2006.01) | ||
C07C 317/32 | (2006.01) | ||
C07D 209/08 | (2006.01) | ||
C07D 213/38 | (2006.01) | ||
C07D 213/64 | (2006.01) | ||
C07D 213/70 | (2006.01) | ||
C07D 213/89 | (2006.01) | ||
C07D 215/12 | (2006.01) | ||
C07D 231/12 | (2006.01) | ||
C07D 233/54 | (2006.01) | ||
C07D 239/26 | (2006.01) | ||
C07D 241/12 | (2006.01) | ||
C07D 261/08 | (2006.01) | ||
C07D 263/32 | (2006.01) | ||
C07D 271/06 | (2006.01) | ||
C07D 277/28 | (2006.01) | ||
C07D 295/12 | (2006.01) | ||
C07D 307/52 | (2006.01) | ||
C07D 333/20 | (2006.01) | ||
C07D 401/04 | (2006.01) | ||
C07D 417/04 | (2006.01) | ||
A61P 19/00 | (2006.01) |
(11) | Number of the document | 1482924 |
(13) | Kind of document | T |
(96) | European patent application number | 03716238.5 |
Date of filing the European patent application | 2003-02-28 | |
(97) | Date of publication of the European application | 2004-12-08 |
(45) | Date of publication and mention of the grant of the patent | 2008-05-21 |
(46) | Date of publication of the claims translation | 2008-10-27 |
(86) | Number | PCT/US2003/006147 |
Date | 2003-02-28 |
(87) | Number | WO 2003/075836 |
Date | 2003-09-18 |
(30) | Number | Date | Country code |
361818 P | 2002-03-05 | US | |
408704 P | 2002-09-06 | US |
(72) |
BAYLY, Christopher, I., CA
BLACK, Cameron, CA
LEGER, Serge, CA
LI, Chun Sing, CA
MCKAY, Dan, CA
MELLON, Christophe, CA
GAUTHIER, Jacques Yves, CA
LAU, Cheuk, CA
THERIEN, Michel, CA
TRUONG, Vouy-Linh, CA
GREEN, Michael, J., US
HIRSCHBEIN, Bernard, L., US
JANC, James, W., US
PALMER, James, T., US
BASKARAN, Chitra, US
|
(73) |
AXYS PHARMACEUTICALS, INC.,
180 Kimbal Way, South San Francisco, CA 94080,
US
Merck Canada Inc., 16750 Trans-Canada Highway, Kirkland, Québec H9H 4M7, CA |
(74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Katepsincisteinproteazės inhibitoriai |
CATHEPSIN CYSTEINE PROTEASE INHIBITORS |
Payment date | Validity (years) | Amount | |
2019-02-14 | 17 | 347.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2020-02-28 |